Oncogenic BRAF, unrestrained by TGFß-receptor signalling, drives right-sided colonic tumorigenesis. (2021)
Attributed to:
Examining the relationship between KRAS mutation and immunotherapy resistance in colorectal cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-23717-5
PubMed Identifier: 34103493
Publication URI: http://europepmc.org/abstract/MED/34103493
Type: Journal Article/Review
Volume: 12
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723